-
公开(公告)号:US20240245514A1
公开(公告)日:2024-07-25
申请号:US18436900
申请日:2024-02-08
发明人: Sonny Sheth , David Arazawa , j. Brook Burley , Sarah Elizabeth Smith , Matthew B. Havener , James San Antonio , Marc Gilles Long
IPC分类号: A61F2/28 , A61F2/30 , A61F2/46 , A61L27/02 , A61L27/26 , A61L27/36 , A61L27/40 , A61L31/00 , A61L31/12 , A61L31/16
CPC分类号: A61F2/28 , A61F2/30767 , A61F2/4601 , A61L27/02 , A61L27/025 , A61L27/3645 , A61L27/365 , A61L27/40 , A61L31/005 , A61L31/127 , A61L31/16 , A61F2002/2835 , A61F2002/3006 , A61F2002/30062 , A61F2002/3093 , A61F2/30965 , A61L27/26 , A61L2420/02 , A61L2420/06 , C12N2533/18
摘要: A bioactive filamentary structure includes a sheath coated with a mixture of synthetic bone graft particles and a polymer solution forming a scaffold structure. In forming such a structure, synthetic bone graft particles and a polymer solution are applied around a filamentary structure. A polymer is precipitated from the polymer solution such that the synthetic bone graft particles and the polymer coat the filamentary structure and the polymer is adhered to the synthetic bone graft particles to retain the graft particles.
-
公开(公告)号:US20230046290A1
公开(公告)日:2023-02-16
申请号:US17888262
申请日:2022-08-15
申请人: IVIVA Medical, Inc.
摘要: Disclosed are apparatus and methods for blood and other biological fluid purification using a membrane with cell containing vascular channel systems and filtration channel systems. Also disclosed are methods of making the apparatus as well as methods of making membranes.
-
公开(公告)号:US10912864B2
公开(公告)日:2021-02-09
申请号:US16428505
申请日:2019-05-31
发明人: Benjamin Schilling , Andrew Madans , Abigail Phipps , Thomas Tylutki , Todd Nilsen , Yen-Chen Huang , Evangelia Chnari
摘要: Compositions including a first soft tissue-derived matrix and a second soft tissue-derived matrix are provided, as well as methods of making such compositions. In some embodiments, the composition comprises delipidated, decellularized adipose tissue-derived matrix and delipidated, decellularized fascial tissue-derived matrix, which may be combined in various proportions. Such adipose-fascia matrix compositions provide improved volume retention when implanted into a patient. The composition may further include exogenous cells or other substances, and/or a carrier. The composition is suitable for use inplastic surgery procedures, including reconstructive or cosmetic surgery procedures, as well as procedures for wound treatment and tissue regeneration. The methods for making the compositions may involve separation of first and second soft tissues from one another, followed by performing one or more treatments on the separated soft tissues, then combining the treated soft tissues and, optionally, performing one or more additional treatments on the combined soft tissues.
-
公开(公告)号:US10828395B2
公开(公告)日:2020-11-10
申请号:US15298142
申请日:2016-10-19
发明人: Thomas E. Uveges , Jin-Qiang Kuang , Alla Danilkovitch , S. Michael Sinclair , Sandra D. Geraghty
摘要: Provided herein is a bone repair composition that is composed of periosteum containing an angiogenic growth factor(s), cancellous bone chips containing viable osteogenic cells, and, optionally, demineralized bone matrix (DBM) chips. Also provided herein are articles of manufacture and methods of use thereof to treat bone defects.
-
公开(公告)号:US20200316256A1
公开(公告)日:2020-10-08
申请号:US16903920
申请日:2020-06-17
摘要: One aspect of the present disclosure can include a biocompatible tissue graft. The graft can include an extracellular matrix (ECM) patch or strip and at least one fiber stitched into the ECM patch or strip in a peripheral reinforcement pattern. The at least one fiber can have opposing terminal ends. The at least one fiber can mitigate tearing and/or improve fixation retention of the ECM patch or strip. The at least one fiber can comprise a plurality of interconnected stitches. The opposing terminal ends of the at least one fiber can be stitched together to form a continuous stitching construction.
-
公开(公告)号:US10758644B2
公开(公告)日:2020-09-01
申请号:US14097328
申请日:2013-12-05
摘要: A biocompatible tissue graft is provided. The tissue graft includes an extracellular matrix patch and a means for reinforcing the patch.
-
7.
公开(公告)号:US20200054787A1
公开(公告)日:2020-02-20
申请号:US16495683
申请日:2018-03-23
IPC分类号: A61L27/34 , A61L27/36 , A61L29/00 , A61L29/08 , A61L31/00 , A61L31/10 , A61L27/50 , A61L29/14 , A61L31/14 , A61L27/06 , A61L27/10 , A61L27/40 , A61L29/02 , A61L29/12 , A61L31/02 , A61L31/12 , A61L27/54 , A61L29/16 , A61L31/16 , D01D5/00 , D01F4/02
摘要: The present invention disclosed a process to coat the surface of flexible polymeric implant with biocompatible polymer such that the coating does not crack when the implant is subjected to mechanical forces such as tension, torsion or bending while retaining the inherent properties of the coated polymer.
-
公开(公告)号:US10562225B2
公开(公告)日:2020-02-18
申请号:US14570853
申请日:2014-12-15
发明人: Jed K. Johnson
IPC分类号: B29C67/00 , A61F2/20 , B29C64/00 , A61L27/36 , A61L27/38 , A61L27/40 , A61F2/04 , B29K67/00 , B29K75/00 , B29K311/00
摘要: A system for manufacturing a synthetic organ suitable for transplantation into a biological organism is provided. This synthetic organ includes a three-dimensional polymer scaffold, wherein the shape and dimensions of the polymer scaffold are based on a native organ, wherein the polymer scaffold further includes at least one layer of polymer fibers that have been deposited by electrospinning, and wherein the orientation of the fibers in the scaffold relative to one another is generally parallel, random, or both; and wherein the polymer scaffold has been preseeded with at least one type of biological cell prior to implantation into a biological organism, and wherein the at least one type of biological cell is operative to facilitate integration of the polymer scaffold into the organism so that the polymer scaffold may function in a manner significantly similar to or the same as the native organ.
-
公开(公告)号:US10543296B2
公开(公告)日:2020-01-28
申请号:US15767610
申请日:2016-06-07
发明人: Haiping Qi , Ziqiang Liu , Li Qin , Deyuan Zhang , Wenjiao Lin
摘要: Absorbable iron-based alloy implanted medical device and manufacturing method thereof. The iron-based alloy implanted medical device comprises an iron-based alloy substrate (11), a degradable polymer layer (13) disposed on a surface of the iron-based alloy substrate (11), and a tannic acid chemical conversion film (12) disposed on a surface of the iron-based alloy substrate (11). After the medical device is implanted into a body, the tannic acid chemical conversion film (12) is configured to protect the iron-based alloy substrate (11) coated thereby from being in contact with a body fluid, thereby ensuring that the device meets a clinical mechanical property requirement in the early stage of implantation. Furthermore, the iron-based alloy implanted medical device has a decreased size, and produces a decreased amount of a corrosive product after being implanted, facilitating faster absorption or elimination of the corrosive product.
-
公开(公告)号:US20190142569A1
公开(公告)日:2019-05-16
申请号:US16189138
申请日:2018-11-13
申请人: Kyoto University
发明人: Tatsuo Nakamura , Yuji Inada , Keiji Shigeno
摘要: Disclosed is an artificial trachea comprising: a hollow tubular base material whose cross-section in a direction orthogonal to the central axis of the tube has an approximately circular shape.
-
-
-
-
-
-
-
-
-